Lotus Pharmaceuticals, Inc. (LTUS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2010 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.13 Thousand | -23.81 Thousand | -30.41 Thousand | -6283.00 | -21.82 Thousand | 26.77 Million |
| Net Income | -18.81 Thousand | -21.1 Thousand | -30.41 Thousand | -6283.00 | -21.82 Thousand | 14.42 Million |
| Depreciation & Amortization | - | - | - | - | - | 2.24 Million |
| Deferred income taxes | - | - | - | - | - | 6.96 Million |
| Stock-based compensation | - | - | - | - | - | 246 Thousand |
| Change in working capital | -320.00 | -2710.00 | - | - | - | 1.77 Million |
| Other non-cash items | 200.00 | 2550.00 | - | - | - | 8.08 Million |
| Investing Cash Flow | - | - | - | - | 8509.00 | -29.44 Million |
| Investments in PPE | - | - | - | - | - | -29.44 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 8509.00 | - |
| Financing Cash Flow | 19.88 Thousand | 17.3 Thousand | 36.34 Thousand | 7995.00 | 30.36 Thousand | - |
| Debt repayment | -19.88 Thousand | -17.3 Thousand | -36.34 Thousand | -7995.00 | -30.36 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 34.6 Thousand | 72.68 Thousand | 15.99 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | -124.97 Thousand |
| Accounts payables | -200.00 | -2550.00 | - | - | - | 36.89 Thousand |
| Inventory | - | - | - | - | - | 429.87 Thousand |
| Other working capital | -120.00 | -160.00 | - | - | - | 2.85 Million |
| Cash at beginning of period | 1153.00 | 7670.00 | 1743.00 | 31.00 | 1.33 Million | 3.94 Million |
| Cash at end of period | 1901.00 | 1153.00 | 7670.00 | 1743.00 | 31.00 | 1.33 Million |
| Capital Expenditure | - | - | - | - | - | -29.44 Million |
| Effect of forex changes on cash | - | - | - | - | -1.35 Million | 67.02 Thousand |
| Net cash flow / Change in cash | 748.00 | -6517.00 | 5927.00 | 1712.00 | -1.33 Million | -2.6 Million |
| Free Cash Flow | -19.13 Thousand | -23.81 Thousand | -30.41 Thousand | -6283.00 | -21.82 Thousand | -2.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2500.00 | -5732.00 | -18.81 Thousand | -3622.00 | -4425.00 | -4150.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -320.00 | -1950.00 | 1830.00 | - |
| Other non-cash items | -1347.00 | 1347.00 | 200.00 | - | - | -2430.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2750.00 | 4000.00 | 19.88 Thousand | 7280.00 | 2600.00 | 6000.00 |
| Debt repayment | -2750.00 | -4000.00 | -19.88 Thousand | -7280.00 | -2600.00 | -6000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | -200.00 | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -120.00 | -1950.00 | 1830.00 | - |
| Cash at beginning of period | 1109.00 | 1901.00 | 1153.00 | 193.00 | 188.00 | 768.00 |
| Cash at end of period | 419.00 | 1109.00 | 1901.00 | 1901.00 | 193.00 | 188.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -690.00 | -792.00 | 748.00 | 1708.00 | 5.00 | -580.00 |
| Free Cash Flow | -3847.00 | -4385.00 | -19.13 Thousand | -5572.00 | -2595.00 | -6580.00 |
SRAX
600667
TTI
CAT-A
TNISF
ILYDA